Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colorectal Neoplasms × IFL protocol × Clear all

Phase

Status

Sponsor Class

INDUSTRY 53 OTHER 27 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Irinotecan 11 Oxaliplatin 8 Cetuximab 7 Fluorouracil 6 Leucovorin 5 Bevacizumab 5 S 1 (combination) 4 Capecitabine 4 Standard of Care 3 trifluridine tipiracil drug combination 2 tislelizumab 2 apatinib 2 Propranolol 2 Preoperative Exercise 2 Panitumumab 2 Levoleucovorin 2 Folfox protocol 2 Etodolac 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trebananib 1 regorafenib 1 envafolimab 1 Trifluridine 1 Thalidomide 1 Surveys and Questionnaires 1 Occult Blood 1 Neoadjuvant Therapy 1 Moxibustion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03940131 2022-04-06

REPAN

King Abdullah Medical City

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡